Results 141 to 150 of about 10,444,260 (254)

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

Portrait of John Coburn, 1988 [picture] /

open access: yes, 1988
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/20/R.; Also available online at: http://nla.gov.au/nla.pic ...
Weight, Greg, 1946-
core  

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni   +19 more
wiley   +1 more source

Portrait of Michael Snape, 1992 [picture] /

open access: yes, 1992
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/21/R.; Also available online at: http://nla.gov.au/nla.pic ...
Weight, Greg, 1946-
core  

Corrigendum to “Impaired Visual Motor Coordination in Obese Adults”

open access: yesJournal of Obesity, 2018
David Gaul   +3 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Portrait of Arthur Boyd, 1993 [picture] /

open access: yes, 1993
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/5/R.; Also available online at: http://nla.gov.au/nla.pic-an12117808; Exhibited: In the Picture, NPG ...
Weight, Greg, 1946-
core  

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Portrait of Brett Whiteley, 1973 [picture] /

open access: yes, 1973
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/9/R.; Also available online at: http://nla.gov.au/nla.pic ...
Weight, Greg, 1946-
core  

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy